CLOV
Clover Health Investments, Corp · Healthcare · Healthcare Plans
$4.46
-2.62% today · -3.04% 1W
Oct 30 close or latest
ReadoutWhy it's moving
Underperforming without a clear catalyst yet
- CLOV −2.62% on the last session vs SPY −1.77%: −0.8 pts of stock-specific move.
- Earnings Wed after the close: EPS $0.01 expected (1 analysts); it moved ±11.2% on average after its last 8 reports.
- 8 insider or congressional trades in the past 30 days.
Assembled from Wallsti's own signals.
Activity & positioning
- Volume
- 1.1× its 20-day averageOct 30 session
- Short interest
- 5.5% of float · -3% vs prior report · 5.6 days to cover as of Sep 30
- Options volume
- —
- Implied volatility
- —
- Options-implied move
- —
Moved with
Health care ETF (XLV) +0.5% +2.2 pts vs SPY
Key facts
- Market cap
- $2.5B
- Held by institutions
- 33.9%
- 52-week range
- 1.58–5.59
- Analyst mean target
- —
- Next earnings
- Nov 4 AMC
- Forward P/E
- 31.9
Recent events
Insider ▼
Jamie L. Reynoso (CEO, Medicare Advantage) sold 4,066 shares ($17.9K) under a pre-arranged 10b5-1 plan 10b5-1 plan · filingInsider ▼
Jamie L. Reynoso (CEO, Medicare Advantage) sold 18,273 shares ($85.5K) under a pre-arranged 10b5-1 plan 10b5-1 plan · filingInsider ▼
Conrad Wai (CEO, Counterpart Health) sold 23,627 shares ($110.6K) under a pre-arranged 10b5-1 plan 10b5-1 plan · filingInsider ▼
Joseph Clay Thornton (Interim CFO) sold 4,591 shares ($21.5K) under a pre-arranged 10b5-1 plan 10b5-1 plan · filingInsider ▼
Karen Soares (Chief Legal Officer) sold 14,673 shares ($68.7K) under a pre-arranged 10b5-1 plan 10b5-1 plan · filingInsider ▼
Andrew Toy (Chief Executive Officer, Director) sold 62,176 shares ($291.0K) under a pre-arranged 10b5-1 plan 10b5-1 plan · filingSEC filing
8-K: Reg FD disclosure (item 7.01) · filingInsider ▼
Jamie L. Reynoso (CEO, Medicare Advantage) sold 2,006 shares ($9.3K) under a pre-arranged 10b5-1 plan 10b5-1 plan · filingInsider ▼
Jamie L. Reynoso (CEO, Medicare Advantage) sold 8,750 shares ($38.7K) under a pre-arranged 10b5-1 plan 10b5-1 plan · filingInsider ▼
Andrew Toy (Chief Executive Officer, Director) sold 318,806 shares ($1.3M) under a pre-arranged 10b5-1 plan 10b5-1 plan · filingSEC filing
8-K: executive or director change (item 5.02) · filingInsider ▼
Jamie L. Reynoso (CEO, Medicare Advantage) sold 1,921 shares ($8.8K) under a pre-arranged 10b5-1 plan 10b5-1 plan · filing